New Resorcinol-Anandamide "Hybrids" as Potent Cannabinoid Receptor Ligands Endowed with Antinociceptive Activity in Vivo

被引:16
作者
Brizzi, Antonella [1 ]
Brizzi, Vittorio [1 ]
Cascio, Maria Grazia [2 ]
Corelli, Federico [1 ]
Guida, Francesca
Ligresti, Alessia [2 ]
Maione, Sabatino
Martinelli, Adriano [3 ]
Pasquini, Serena [1 ]
Tuccinardi, Tiziano [3 ,4 ]
Di Marzo, Vincenzo [2 ]
机构
[1] Univ Siena, Dipartimento Farm Chim Tecnol, I-53100 Siena, Italy
[2] CNR, Ist Chim Biomol, Endocannabinoid Res Grp, I-80078 Naples, Italy
[3] Univ Pisa, Dipartimento Sci Farmaceut, I-56126 Pisa, Italy
[4] Temple Univ, Coll Sci & Technol, Ctr Biotechnol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA
关键词
CARDIOMETABOLIC RISK-FACTORS; ENDOCANNABINOID SYSTEM; FORMALIN TEST; MOLECULAR CHARACTERIZATION; SCORING PROPERTIES; SMOKING-CESSATION; LYSINE RESIDUE; BRAIN; ANALOGS; BINDING;
D O I
10.1021/jm8016255
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Bearing in mind the pharmacophoric requirements of both (-)-trans-Delta(9)-tetrahydrocannabinol (THC) and anandamide (AEA), we designed a novel pharmacophore consisting of both a rigid aromatic backbone and a flexible chain with the aim to develop a series of stable and potent ligands of cannabinoid receptors. In this paper we report the synthesis, docking studies, and structure-activity relationships of new resorcinol-anandamide "hybrids" differing in the side chain group. Compounds bearing a 2-methyloctan-2-yl group at position 5 showed a significantly higher affinity for cannabinoid (CB) receptors, in particular when an alkyloxy chain of 7 or 10 carbon atoms was also present at position 1. Derivative 32 was a potent CB(1) and CB(2) ligand, with K(i) values similar to that of WIN 55-212 and potent antinociceptive activity in vivo. Moreover, derivative 38, although less potent, proved to be the most selective ligand for CB, receptor (K(i)(CB(1)) = 1 mu M, K(i)(CB(2)) = 35 nM).
引用
收藏
页码:2506 / 2514
页数:9
相关论文
共 60 条
[11]   Design, synthesis, binding, and molecular modeling studies of new potent ligands of cannabinoid receptors [J].
Brizzi, Antonella ;
Cascio, Maria Grazia ;
Brizzi, Vittorio ;
Bisogno, Tiziana ;
Dinatolo, Maria Teresa ;
Martinelli, Adriano ;
Tuccinardi, Tiziano ;
Di Marzo, Vincenzo .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (16) :5406-5416
[12]   In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands [J].
Cascio, M. G. ;
Bisogno, T. ;
Palazzo, E. ;
Thomas, A. ;
van der Stelt, M. ;
Brizzi, A. ;
De Novellis, V. ;
Marabese, I. ;
Ross, R. ;
van de Doelen, T. ;
Brizzi, V. ;
Pertwee, R. ;
Maione, S. ;
Di Marzo, V. .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 149 (04) :431-440
[13]   Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides [J].
Cravatt, BF ;
Giang, DK ;
Mayfield, SP ;
Boger, DL ;
Lerner, RA ;
Gilula, NB .
NATURE, 1996, 384 (6604) :83-87
[14]   Cyclic dipeptides.: 3.: Synthesis of methyl (R)-6-[(tert-butoxycarbonyl)amino]-4,5,6,7-tetrahydro-2-methyl-5-oxo-1,4-thiazepine-3-carboxylate and its hexahydro analogues:: Elaboration of a novel dual ACE NEP inhibitor [J].
Crescenza, A ;
Botta, M ;
Corelli, F ;
Santini, A ;
Tafi, A .
JOURNAL OF ORGANIC CHEMISTRY, 1999, 64 (09) :3019-3025
[15]  
DEVANE WA, 1988, MOL PHARMACOL, V34, P605
[16]   ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR [J].
DEVANE, WA ;
HANUS, L ;
BREUER, A ;
PERTWEE, RG ;
STEVENSON, LA ;
GRIFFIN, G ;
GIBSON, D ;
MANDELBAUM, A ;
ETINGER, A ;
MECHOULAM, R .
SCIENCE, 1992, 258 (5090) :1946-1949
[17]   A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid [J].
Di Marzo, V ;
Griffin, G ;
De Petrocellis, W ;
Brandi, I ;
Bisogno, T ;
Williams, W ;
Grier, MC ;
Kulasegram, S ;
Mahadevan, A ;
Razdan, RK ;
Martin, BR .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (03) :984-991
[18]   The endocannabinoid system and its therapeutic exploitation [J].
Di Marzo, V ;
Bifulco, M ;
De Petrocellis, L .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (09) :771-784
[19]   A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists [J].
Di Marzo, V .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (03) :134-140
[20]   Plant, synthetic, and endogenous cannabinoids in medicine [J].
Di Marzo, V ;
De Petrocellis, L .
ANNUAL REVIEW OF MEDICINE, 2006, 57 :553-574